Literature DB >> 23910468

Impact of human papillomavirus on oropharyngeal cancer biology and response to therapy: implications for treatment.

Juliana Bonilla-Velez1, Edmund A Mroz, Rebecca J Hammon, James W Rocco.   

Abstract

Oropharyngeal squamous cell carcinoma (OPSCC) originating from human papillomavirus infection has emerged as a new entity in head and neck cancer, defining a subset of patients with distinct carcinogenesis, risk factor profiles, and clinical presentation that show markedly improved survival than patients with classic OPSCC. De-escalation of therapy and identification of relevant biomarkers to aid in patient selection are actively being investigated. This review addresses the implications of these findings in clinical care.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Clinical implications; HPV-positive oropharyngeal cancer; Treatment implications

Mesh：

Substances：

Year:  2013        PMID： 23910468      PMCID： PMC3740406          DOI： 10.1016/j.otc.2013.04.009

Source DB:  PubMed          Journal:  Otolaryngol Clin North Am        ISSN： 0030-6665            Impact factor:   3.346


  63 in total

1.  Tissue distribution of human papillomavirus 16 DNA integration in patients with tonsillar carcinoma.

Authors:  Shahnaz Begum; Dengfeng Cao; Maura Gillison; Marianna Zahurak; William H Westra
Journal:  Clin Cancer Res       Date:  2005-08-15       Impact factor: 12.531

Review 2.  Exploring biomarkers in head and neck cancer.

Authors:  Corey J Langer
Journal:  Cancer       Date:  2012-01-26       Impact factor: 6.860

Review 3.  Second malignant neoplasms and cardiovascular disease following radiotherapy.

Authors:  Lois B Travis; Andrea K Ng; James M Allan; Ching-Hon Pui; Ann R Kennedy; X George Xu; James A Purdy; Kimberly Applegate; Joachim Yahalom; Louis S Constine; Ethel S Gilbert; John D Boice
Journal:  J Natl Cancer Inst       Date:  2012-02-06       Impact factor: 13.506

4.  High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma.

Authors:  Lisa Licitra; Federica Perrone; Paolo Bossi; Simona Suardi; Luigi Mariani; Raffaella Artusi; Maria Oggionni; Chiara Rossini; Giulio Cantù; Massimo Squadrelli; Pasquale Quattrone; Laura D Locati; Cristiana Bergamini; Patrizia Olmi; Marco A Pierotti; Silvana Pilotti
Journal:  J Clin Oncol       Date:  2006-12-20       Impact factor: 44.544

Review 5.  Human papillomavirus oncoproteins: pathways to transformation.

Authors:  Cary A Moody; Laimonis A Laimins
Journal:  Nat Rev Cancer       Date:  2010-07-01       Impact factor: 60.716

6.  Human papillomavirus (HPV) DNA in tonsillar cancer: clinical correlates, risk of relapse, and survival.

Authors:  H Mellin; S Friesland; R Lewensohn; T Dalianis; E Munck-Wikland
Journal:  Int J Cancer       Date:  2000-05-20       Impact factor: 7.396

7.  Validation of methods for oropharyngeal cancer HPV status determination in US cooperative group trials.

Authors:  Richard C Jordan; Mark W Lingen; Bayardo Perez-Ordonez; Xin He; Robert Pickard; Michael Koluder; Bo Jiang; Paul Wakely; Weihong Xiao; Maura L Gillison
Journal:  Am J Surg Pathol       Date:  2012-07       Impact factor: 6.394

Review 8.  Human papillomavirus in HNSCC: recognition of a distinct disease type.

Authors:  Laura Vidal; Maura L Gillison
Journal:  Hematol Oncol Clin North Am       Date:  2008-12       Impact factor: 3.722

Review 9.  Epidemiology of human papillomavirus-related head and neck cancer.

Authors:  Andrew W Joseph; Gypsyamber D'Souza
Journal:  Otolaryngol Clin North Am       Date:  2012-05-31       Impact factor: 3.346

10.  The role of transoral robotic surgery in the management of oropharyngeal cancer: a review of the literature.

Authors:  Samuel A Dowthwaite; Jason H Franklin; David A Palma; Kevin Fung; John Yoo; Anthony C Nichols
Journal:  ISRN Oncol       Date:  2012-04-23
View more
  15 in total

1.  Validation of an updated evidence-based protocol for proactive gastrostomy tube insertion in patients with head and neck cancer.

Authors:  T E Brown; V Getliffe; M D Banks; B G M Hughes; C Y Lin; L M Kenny; J D Bauer
Journal:  Eur J Clin Nutr       Date:  2016-02-10       Impact factor: 4.016

2.  Survival analysis of 287 oropharyngeal squamous cell carcinoma patients in a single institution: a retrospective comparison of two consecutive time intervals with surgical and conservative treatment approaches.

Authors:  Adrian Münscher; Lara Bussmann; Susanne Sehner; Simon Knaack; Alexandra Gliese; Silke Tribius; Till Clauditz; Balazs B Lörincz
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-05-29       Impact factor: 2.503

3.  Mutant allele tumor heterogeneity (MATH) and head and neck squamous cell carcinoma.

Authors:  James W Rocco
Journal:  Head Neck Pathol       Date:  2015-03-25

4.  Detection of human papillomavirus (HPV) in clinical samples: evolving methods and strategies for the accurate determination of HPV status of head and neck carcinomas.

Authors:  William H Westra
Journal:  Oral Oncol       Date:  2014-06-02       Impact factor: 5.337

5.  Human Papillomavirus and Oropharyngeal Squamous Cell Carcinoma of the Head and Neck: A Growing Epidemic.

Authors:  Jessica Bauman; Lori Wirth
Journal:  Adolesc Med State Art Rev       Date:  2014-08

6.  Large Cell Neuroendocrine Carcinoma of the Head and Neck: A Clinicopathologic Series of 10 Cases With an Emphasis on HPV Status.

Authors:  Elizabeth D Thompson; Edward B Stelow; Stacey E Mills; William H Westra; Justin A Bishop
Journal:  Am J Surg Pathol       Date:  2016-04       Impact factor: 6.394

Review 7.  Molecular Aspects of Head and Neck Cancer Therapy.

Authors:  Sidharth V Puram; James W Rocco
Journal:  Hematol Oncol Clin North Am       Date:  2015-10-17       Impact factor: 3.722

8.  Priorities and Preferences of Patients With Head and Neck Cancer for Discussing and Receiving Information About Sexuality and Perception of Self-Report Measures.

Authors:  Bethany A Rhoten; Amanda J Davis; Breanna N Baraff; Kelly H Holler; Mary S Dietrich
Journal:  J Sex Med       Date:  2020-05-13       Impact factor: 3.802

9.  Intra-tumor genetic heterogeneity and mortality in head and neck cancer: analysis of data from the Cancer Genome Atlas.

Authors:  Edmund A Mroz; Aaron D Tward; Aaron M Tward; Rebecca J Hammon; Yin Ren; James W Rocco
Journal:  PLoS Med       Date:  2015-02-10       Impact factor: 11.069

10.  Quantitative assessment of p16 expression in FNA specimens from head and neck squamous cell carcinoma and correlation with HPV status.

Authors:  Rita Abi-Raad; Manju L Prasad; Syed Gilani; James Garritano; Deborah Barlow; Guoping Cai; Adebowale J Adeniran
Journal:  Cancer Cytopathol       Date:  2020-12-28       Impact factor: 5.284
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.